Eric Easom 13D/13G Filings for AN2 Therapeutics, Inc. (ANTX)

Eric Easom 13D and 13G filings for AN2 Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-13
4:30 pm
Purchase
2024-12-31 13G AN2 Therapeutics, Inc.
ANTX
Eric Easom 1,893,132
6.200%
320,962increase
(+20.42%)
Filing
2024-02-13
5:11 pm
Purchase
2022-12-31 13G AN2 Therapeutics, Inc.
ANTX
Eric Easom 1,572,170
5.200%
1,572,170increase
(New Position)
Filing